Hepion Pharmaceuticals, Inc. HEPA
HEPA
Hepion Pharmaceuticals, Inc. TECX
Tectonic Therapeutic, Inc. OCEA
Ocean Biomedical, Inc. ENVB
Enveric Biosciences, Inc. ELEV
Elevation Oncology, Inc. HOTH
Hoth Therapeutics, Inc. PSTV
Plus Therapeutics, Inc. PHIO
Phio Pharmaceuticals Corp. BXRXQ
Baudax Bio, Inc. SONN
Sonnet BioTherapeutics Holdings, Inc.
Hepion Pharmaceuticals, Inc. TECX
Tectonic Therapeutic, Inc. OCEA
Ocean Biomedical, Inc. ENVB
Enveric Biosciences, Inc. ELEV
Elevation Oncology, Inc. HOTH
Hoth Therapeutics, Inc. PSTV
Plus Therapeutics, Inc. PHIO
Phio Pharmaceuticals Corp. BXRXQ
Baudax Bio, Inc. SONN
Sonnet BioTherapeutics Holdings, Inc.
Performance
| Periode | HEPA | TECX | OCEA | ENVB | ELEV | HOTH | PSTV | PHIO | BXRXQ | SONN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -83.00 % | -0.87 % | -84.14 % | -50.00 % | -39.91 % | 97.30 % | -6.68 % | 26.55 % | 0.00 % | 241.86 % |
| YTD | -99.71 % | -64.94 % | -98.84 % | -89.32 % | -38.67 % | 105.17 % | -40.69 % | 15.89 % | 900.00 % | 175.63 % |
| 1Y | -99.75 % | -52.53 % | -99.24 % | -89.89 % | -54.38 % | 92.68 % | -46.98 % | -18.14 % | -90.00 % | -4.75 % |
| 3Y | -99.98 % | 122.50 % | -99.93 % | -98.88 % | -70.80 % | -80.57 % | -90.67 % | -96.48 % | -99.96 % | -98.03 % |
| 5Y | -100.00 % | -91.18 % | -99.93 % | -99.98 % | -96.81 % | -96.60 % | -98.21 % | -99.06 % | -99.96 % | -99.97 % |
| 10Y | -100.00 % | -95.72 % | -99.93 % | -100.00 % | -96.81 % | -99.26 % | -100.00 % | -100.00 % | -99.96 % | -100.00 % |
| From the beginning | -100.00 % | -95.72 % | -99.93 % | -100.00 % | -96.81 % | -99.26 % | -100.00 % | -99.30 % | -99.96 % | -100.00 % |